NCI/PCF Launch Largest Ever African-American Prostate Cancer Study
The RESPOND study, funded by NCI, National Institute on Minority Health and Health Disparities (NIMHD) and the Prostate Cancer Foundation (PCF), will investigate environmental and genetic factors related to aggressiveness of prostate cancer in African-American men.
Nobody wants to think about cancer, especially prostate cancer. Nobody wants to get screened, and especially, nobody wants to even think about getting a rectal exam to check for prostate cancer. We get that.
PCF identifies the most promising research ideas and attracts brilliant individuals and teams of scientists, early in their careers, to PCF’s Research Enterprise. By channeling resources directly to the world’s top scientific minds, PCF is able to cut through red tape, speed scientific breakthroughs and deliver new treatments to patients.
The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $755 million and provided funding to more than 2,000 research programs at more than 200 cancer centers and universities. The PCF global research enterprise extends to 22 countries and funds a robust research portfolio. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer.